Articles On Telix Pharmaceuticals (ASX:TLX)

Radiopharm Theranostics (ASX:RAD) pales in size relative to ASX peer Telix Pharmaceuticals and US nuclear medicine titan Lantheus, but CEO Riccardo Canevari is happy to walk in the shadow of giants. Canevari notes the duo’s pioneering role...

Highlights ASX set to ease after strong record run Global cues shape investor sentiment Corporate earnings remain in spotlight The ASX is expected to take a breather after a stretch of record highs, with futures pointing to a soft...

ASX closes out week-long rally on new record high of 8938 points Market set a new intraday high every day this week Broad sector strength, led by financials and materials   From strength to strength The ASX’s trade performance this week h...

There’s nothing like a great biotech rivalry, such as the one between radio-pharmaceutical peers Clarity Pharmaceuticals (ASX:CU6) and Telix Pharmaceuticals (ASX:TLX). Raising the stakes, Clarity executive chairman Dr Alan Taylor makes a ba...

Despite myriad pressures under the Trump regime, the FDA’s drug and device approval process largely has been unfettered Telix Pharmaceuticals expects a company-making approval decision by the end of the month Painchek is among a string of...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin An additional news report on the recommendation, valuation, forecast and opinion cha...

Every week, hundreds of companies go through the ups and downs of the ASX rollercoaster, with fortunes made and equity lost each time the bourse opens – which is why keeping an eye on the hot stocks is so key. Listen to the HotCopper pod...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin This week's In Brief has a selection of growing winners with upside potential and st...

  Highlights Rebalance across S&P/ASX indices to reshape index composition Passive investment strategies drive significant stock movements Stocks with strong momentum may attract increased fund flows asx today 200...

Many of Australia's top brokers have been busy adjusting their financial models and recommendations again. This has led to the release of a number of broker notes this week. Three ASX shares that brokers have named as buys this week are lis...

  Highlights Market sentiment lifted by expectations of softer monetary policy across global economies Key sectors including consumer discretionary and financials contributed to the upswing Prominent gains noted among diver...

Nanosonics has hit the double jackpot with its second FDA approval for the year Investor fatigue? Amplia shares tumble after further encouraging pancreatic cancer trial data Duelling parties in the Mayne Group (non) takeover offer stick...

With multiple clinical trials and approval applications in train, nuclear medicine superstar Telix Pharmaceuticals (ASX:TLX) is like one of those irritatingly brilliant all-round students. We’re thinking of the straight-A school captain who...

The ASX200 was trading higher approaching close after a day of buoyant investor sentiment. Discretionary, Real Estate and IT sectors lead the bourse into positive territory on a day when all sectors were solidly in the green. In the G...

  Highlights ASX outlook buoyed by defensive sector strength and investor optimism Credit Corp stock gains following strong performance update Defence and renewable infrastructure deals drive key company movements Aus...

  Highlights Asian equities reflect optimism on global policy easing expectations. Australia’s benchmark index gains traction across major sectors. Global trade tensions and local earnings updates add to market momentum....

  Highlights Rare earth stocks advanced following government intervention signals Broader market posted early gains across all major sectors Several company updates influenced intraday movements asx200 showed upward m...

Greetings and welcome to HotCopper‘s Trends article for Tuesday 5th of August, running through the most popular announcements on the website around (late) lunch. Today I’m hereafter skipping over Trigg Minerals which has issued a tradin...

The S&P/ASX 200 Index (ASX: XJO) is having a strong session on Tuesday. In afternoon trade, the benchmark index is up 1% to 8,750 points. Four ASX shares that have failed to follow the market higher today are listed below. Here's why th...

Highlights Gold sector sees strong momentum Major defence contract win boosts confidence Corporate updates shape market direction The ASX opened on a firm note today, with gains seen across various sectors as traders responded to...

S&P/ASX 200 Index (ASX: XJO) healthcare share Telix Pharmaceuticals Ltd (ASX: TLX) is marching higher today. Shares in the diagnostic and therapeutic product developer closed trading for $20.15 on Friday. In afternoon trade on Monday, s...

S&P/ASX 200 Index (ASX: XJO) shares rose 2.35% in July and finished the month at 8,742.8 points on Thursday. The benchmark index closed 0.92% lower yesterday at 8,662 points. In July, the experts upgraded these nine ASX 200 shar...

Highlights ASX 200 dips as material and energy sectors underperform Technology and consumer shares gain on upbeat retail data Lithium, copper, and iron ore stocks lead intraday pullback The ASX 200 companies ended the...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and INDIANAPOLIS, July 30, 2025 /PRNewswire/ — Telix Pharmac...

ASX health stocks rally 5.4% over five days as Morgans’ Scott Power says optimism is returning to the sector The sector’s largest stock CSL is up 10% over past two weeks with other key plays also showing momentum  With new CEO Terri Thomas...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin A mixed bag for this week's In Brief, good and bad news characterised quarterly upda...

Highlights Aussie share market lifted by upbeat trade developments Miners and energy players saw widespread gains Banking stocks contributed to sector-wide momentum Australia's benchmark indices saw a broad rally midwe...

Highlights: ASX 200 nears record highs driven by miners and energy Iron ore and coal stocks show robust gains Healthcare and uranium stocks face notable pressure The S&P ASX 200 pushed closer to record levels, supp...

Highlights Miners Lift ASX, Tech & Energy Stocks in Focus Telix Faces US Scrutiny, Shares Weaken Codeifai Expands AI Team for Global Push   The Australian share market found its footing in midday trade, helped by strength...

Highlights ASX 200 touched session highs backed by major banks and miners Iron ore futures supported upward momentum for heavyweights Telix and Paladin dropped amid sector-specific movements The Australian sharemarket...

Highlights ASX 200 index trades close to record high Gains led by materials and coal stocks Peter Warren Automotive and Avita Medical see strong rallies The Australian share market advanced strongly on Wednesday, with...

The Telix Pharmaceuticals Ltd (ASX: TLX) share price is down 13% after the business revealed a US subpoena with its quarterly update. Telix is a biopharmaceutical company focused on developing and selling therapeutic and diagnostic radiopha...

Telix Pharmaceuticals (ASX:TLX), the ASX-listed healthcare major that was once almost listed on the Nasdaq composite outright before issuing depositary shares there, has been stung by the U.S. regulator. Listen to the HotCopper podcast f...

Telix faces unwanted US regulatory attention – but it’s not alone Amplia raises $25 million, with another $2.5 million to go A home-grown uni biotech innovation shines again   Telix Pharmaceuticals (ASX:TLX) shares this morning slumped up...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin The S&P500 eked out a new high while profit taking sent the Nasdaq lower ahead o...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and INDIANAPOLIS, July 22, 2025 /PRNewswire/ — Telix Pharmac...

For investors with a long-term mindset, the most powerful force in wealth creation is compounding. Find a high-quality business that can grow earnings consistently, reinvest wisely, and defend its competitive edge — and over time, it can de...

Highlights Tech and resource stocks remain high on short interest radar Several ASX-listed names see rising attention in short data Movement in All Ordinaries constituent reflects shifting sentiment The latest update o...

For investors looking to build wealth over the next decade (and beyond), the key is arguably to focus on high-quality businesses with sustainable competitive advantages and strong growth prospects. But which Australian stocks offer this? Le...

ASX health stocks fall o.92% over past five days as US President Donald Trump renews tariff threat on pharmaceutical imports Morgans believes ASX’s biggest biotech CSL  is currently trading at levels significantly below fair value Cochlear...

Just when it seemed Australia had dodged a bullet with only a 10% tariff, Trump has unleashed a shock 200% tariff proposal on all imported pharmaceuticals. Listen to the HotCopper podcast for in-depth discussions and insights on all the...

On Thursday, the S&P/ASX 200 Index (ASX: XJO) had a good session and charged higher. The benchmark index rose 0.6% to 8,589.2 points. Will the market build on this on Friday and end the week on a high? Here are five things to watch: ASX...

Highlights Australian share market dips with copper-exposed miners under pressure Trade-related tariff concerns weigh on broader resource sentiment Telix Pharmaceuticals outperforms with strong market momentum The Aust...

ASX closes lower on Wednesday, dropping 52.10 points or 0.61% to 8538.60 Seven of 11 ASX sectors were in the red as US President Donald Trump renewed his tariffs push Telix lifts on permanent US healthcare system code for PSMA PET imaging...

Well, it was a rather woeful Wednesday session for the S&P/ASX 200 Index (ASX: XJO) today, with investors decisively sending the markets lower. The ASX 200 spent all day in red territory and ended u...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a disappointing decline. At the time of writing, the benchmark index is down 0.4% to 8,557.4 points. Four ASX shares that are not letting that hold them back to...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia, July 9, 2025 /PRNewswire/ – Telix Pharmaceuticals Limited...

Telix Pharmaceuticals Ltd (ASX: TLX) shares are having a strong session on Wednesday. In afternoon trade, the ASX 200 radiopharmaceuticals company's shares are up 7% to $25.71. This compares favourably to the performance of the benchmark AS...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Rudi Filapek-Vandyck (See also FNArena Talks and Ask FNArena further below). By Rudi Filap...

China Brain Project rolls out neuro-AI push Compumedics dual-helmet MEG lights up Tianjin labs ASX health stocks surge deeper into China   A few years back, China kicked off what might be one of the most ambitious science missions you’ve...